Konstantin Staroselskiy

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

A. Rastogi, S. Fishbane, K. Mccafferty, 2022, BMC Nephrology.

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.

A. Rastogi, S. Fishbane, K. Mccafferty, 2019, Journal of the American Society of Nephrology : JASN.

Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients

A. Rastogi, S. Fishbane, K. Mccafferty, 2022, Kidney international reports.